cbdMD (YCBD) Accounts Payables (2016 - 2026)
cbdMD (YCBD) posted Accounts Payables of $880978.0 for Q4 2025, down 24.94% sequentially from $1.2 million in Q3 2025, and down 24.13% YoY from $1.2 million in Q4 2024.
cbdMD (YCBD) Accounts Payables (2016 - 2026) Analysis & Trends
cbdMD has reported Accounts Payables for 10 years, with the latest figure at $880978.0 in Q4 2025.
- Quarterly Accounts Payables fell 24.13% year-over-year to $880978.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $880978.0 (down 24.13% YoY) and the FY2025 annual result came in at $1.2 million, down 23.84% from the prior year.
- Accounts Payables eased to $880978.0 in Q4 2025 per YCBD's latest filing, from $1.2 million in the prior quarter.
- Over five years, Accounts Payables peaked at $3.7 million in Q4 2021 and troughed at $880978.0 in Q4 2025.
- A 5-year average of $1.9 million and a median of $1.6 million in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2021 and 2022: Accounts Payables surged 72.28% in 2021, then slumped 54.01% in 2022.
- Over 5 years, Accounts Payables stood at $3.7 million in 2021, then sank by 54.01% to $1.7 million in 2022, then slipped by 7.27% to $1.6 million in 2023, then slipped by 25.88% to $1.2 million in 2024, then retreated by 24.13% to $880978.0 in 2025.
- According to Business Quant data, Accounts Payables over the past three periods registered $880978.0, $1.2 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Mn |
| Dec 31, 2025 | 880,978.00 |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 1.57 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 3.67 Mn |
| Sep 30, 2021 | 2.98 Mn |
| Jun 30, 2021 | 3.14 Mn |